Beckman Coulter Life Sciences Introduces 14 New Antibodies

Beckman Coulter Life Sciences is pumping up its flow cytometry portfolio with the addition of 14 new human monoclonal antibodies from Trillium Diagnostics LLC. The analyte-specific reagents (ASRs) provide high specificity, convenience, and flexibility in flow cytometry. A new cell permeabilization reagent is also being offered. 
The new monoclonals include human anti-hemoglobin F, which recognizes fetal hemoglobin molecules; CD163 markers for anti-inflammatory signal and disease research; and CD64 markers, which react with Fc gamma 1 receptors.
Rounding out the line is a monoclonal for MNDA (myeloid nuclear differentiation antigen). All antibodies are available unconjugated or conjugated to a selection of fluorochromes. Intra-Cell concentrate for cell permeabilization is being released at this time as well.